Evaluation of safety and efficacy of Jadwar plant in improving the withdrawal symptoms of opioids
Phase 3
- Conditions
- mental and behavioural disorders due to use of opioids.Opioid related disorders
- Registration Number
- IRCT20170112031893N7
- Lead Sponsor
- Ghoum University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
All patients were abusing opioids for at least 1 year
All patients were at the beginning of induction phase of Methadone maintenance treatment protocol
Subjects should not recieve any other medication which affects withdrawal symptoms
Exclusion Criteria
Any allergies to the active ingredient of the drug or side effects
Getting Cancer
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Opiate withdrawal syndrome score. Timepoint: Baseline, 4,8 and12 weeks after starting the medication. Method of measurement: Opiate withdrawal syndrome questionnaire.
- Secondary Outcome Measures
Name Time Method